- Nachrichtendetail
-
22.03.2024 13:01:57 - dpa-AFX: *ASTELLAS GETS POSITIVE CHMP OPINION FOR XTANDI IN ADDL RECURRENT EARLY PROSTATE CANCER TREATMENT SETTING
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
ASTELLAS PHARMA INC. | 856273 | Frankfurt | 9,646 | 11.07.24 10:31:34 | +0,548 | +6,02% | 9,130 | 9,576 | 9,206 | 9,098 |
